Documents to download
Please enter your e-mail address
Last update : 09/02/2015
One central objective of LeukoTreat was to collect all information necessary for future therapeutic trials on the epidemiology, the natural history, the genotype/phenotype correlation of leukodystrophies, for a sufficient number of patients. To reach this goal, the LeukoDataBase (or LeukoDB) was developed during LeukoTreat, with the aim to be the reference European database on leukodystrophies.
Through the integration of the three existing databases (in France, Italy and Germany), the European LeukoDB thus emerged and is now managed jointly by ELA and Soluscience. Work performed led to the following results:
In this context of data collection, ethics held a central place in LeukoTreat. Ethical issues were therefore fully investigated to promote best practices, produce innovative guidelines and enhance communication with the patients and their families. In particular, experts in ethics and LD patient’s associations worked closely with the research teams for the protection of LD patient’s rights and a better understanding of the patients’ needs.